# Co-FundNI

> Co-FundNI is a VC fund in Belfast backing Software, Health Care and Information Technology. See 44 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Belfast, United Kingdom
- Total investments: 44
- Last investment: Jul 2025
- Lead investor: 18%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/fund-ni/
- X (Twitter): https://twitter.com/CoFundNI
- Website: https://www.cofundni.com

Co-FundNI is a VC fund in Belfast focused on Software and Health Care. Through Co-Fund NI £12.5million will be made available to invest alongside business angels and business angel syndicates (hereafter referred to as "private investors" or "syndicates") into eligible SME's based in Northern Ireland. When matched 45% public with 55% private investors on a deal-by-deal basis this will give anoverall "fund" size of £28m.This initiative is provided by Invest Northern Ireland and part-financed by the European Regional Development Fund under the Invest for Growth and Jobs Programme 2014-2020.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $393k–$1.8M |
| Venture - Series Unknown | $1.9M–$12M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 10 | 23% |
| Health Care | 9 | 20% |
| Information Technology | 7 | 16% |
| Biotechnology | 5 | 11% |
| Medical | 4 | 9% |

73 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 16 | 36% |
| Funding Round | 11 | 25% |
| Venture - Series Unknown | 5 | 11% |
| Series A | 3 | 7% |
| Pre-Seed | 2 | 5% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 35 | 80% |
| Ireland | 1 | 2% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Cumulus Neuroscience | Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. | $4.8M | Venture - Series Unknown | Jul 08, 2025 |  |
| AMPLY Discovery | AMPLY Discovery is to develop new biological molecules for anti-infective health and nutrition applications in animal and human health. | $1.8M | Seed | May 01, 2025 |  |
| GenoMe Diagnostics | GenoMe Diagnostics develops OvaME product that helps in improvement of status quo of CA125 blood tests. | $1.7M | Seed | Mar 03, 2023 |  |
| Kinsetsu | Kinsetsu provides intelligent tracking solutions to help organisations automate and optimise tasks and services. | $1.9M | Venture - Series Unknown | Jan 10, 2023 |  |
| Kinsetsu | Kinsetsu provides intelligent tracking solutions to help organisations automate and optimise tasks and services. | $1.9M | Venture - Series Unknown | Jan 10, 2023 |  |
| Re-Vana Therapeutics | Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company focused on the development and commercialisation of innovative long-acting, biodegradable drug delivery platforms to address ophthalmic conditions such as age-related macular degeneration (AMD), diabetic retinopathy (DR), glaucoma and ocular infections.Their deliveryplatforms enable tailored delivery of therapeutics for long-term and can be administered by various routes to the eye. By using their platform technologies, delivery of a broad range of molecules including proteins, peptides, and small molecules can be achieved from 1 week to 1 year. The platform technologies are based on FDA-approved polymers.Their injectable platform, OcuLief™, can be tailored for the treatment of AMD and DR to achieve a long-term release of anti-vascular endothelial growth factors (anti-VEGF) or corticosteroids for 1-12 months. Their preformed platform, EyeLief™, can be tailored for the treatment of Glaucoma and retina diseases, to achieve a long-term release of small or large molecules for 6 months or more.The design strategy of Re-Vana revolves around increasing patient compliance by reducing pain and frequency of treatment, lowering side effects by controlled drug release, and cost saving for health care providers and pharmaceutical companies. | $12.1M | Series A | Nov 30, 2022 |  |
| CV6 Therapeutics | CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies for the treatment of human diseases. | $5.7M | Venture - Series Unknown | Nov 02, 2022 |  |
| AMPLY Discovery | AMPLY Discovery is to develop new biological molecules for anti-infective health and nutrition applications in animal and human health. | $1M | Seed | Sep 21, 2022 |  |
| VascVersa | VascVersa is a med-tech company specializing in vascular regeneration. | $604.3K | Seed | Aug 08, 2022 |  |
| Sonrai Analytics | Sonrai develop applications and interfaces to utilize the data and the resultant outputs of analysis and combine this with AI and ML to make your data predictive. | $2.6M | Seed | Jun 21, 2022 |  |

10 of 44 investments shown.

## Co-investors
- [QUBIS](https://shizune.co/investors/profile/qubis) — VC Fund, 14 deals together
- [Techstart Ventures](https://shizune.co/investors/profile/techstart-ventures) — VC Fund, 12 deals together
- [HBAN](https://shizune.co/investors/profile/halo-business-angel-network) — VC Fund, 7 deals together
- [Kernel Capital](https://shizune.co/investors/profile/kernel-capital-partners) — VC Fund, 5 deals together
- [Invest Northern Ireland](https://shizune.co/investors/profile/invest-northern-ireland) — VC Fund, 4 deals together
- [Clarendon Fund Managers](https://shizune.co/investors/profile/clarendon-fund-managers) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Imaginary Ventures](https://shizune.co/investors/profile/imaginary-ventures) — VC Fund
- [Distill Ventures](https://shizune.co/investors/profile/distill-ventures) — VC Fund
- [InvestBev](https://shizune.co/investors/profile/investbev) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Fuel Ventures](https://shizune.co/investors/profile/fuel-ventures-fund) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund

## Featured in investor lists
- [Health Care Investors in United Kingdom](https://shizune.co/investors/health-care-investors-united-kingdom)
- [Health Care VC Funds in United Kingdom](https://shizune.co/investors/health-care-vc-funds-united-kingdom)
- [Medical Investors in United Kingdom](https://shizune.co/investors/medical-investors-united-kingdom)
- [Medical VC Funds in United Kingdom](https://shizune.co/investors/medical-vc-funds-united-kingdom)
- [Recruiting VC Funds in United Kingdom](https://shizune.co/investors/recruiting-vc-funds-united-kingdom)
- [Life Science VC Funds in United Kingdom](https://shizune.co/investors/life-science-vc-funds-united-kingdom)

## FAQ

### What does Co-FundNI invest in?

Co-FundNI invests primarily in Software, Health Care and Information Technology startups, most often at Seed and Funding Round stage. Most of the 44 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Co-FundNI's check size?

Co-FundNI typically joins rounds of $393k–$1.8M at Seed and $1.9M–$12M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Co-FundNI participates in.

### When did Co-FundNI last invest?

The most recent investment recorded for Co-FundNI closed in Jul 2025. Shizune tracks 44 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co